New measure of health-related quality of life for patients with oropharyngeal mucositis: Development and preliminary psychometric evaluation

Cancer

Volumn 109, Issue 12, 2007, Pages 2590-2599

  Cheng, Karis Kin Fong ^a   Leung, S F ^a   Thompson, David R ^a   Tai, Josepha W M ^b   Liang, Raymond H S ^c   Kan, Alta S T ^b   Ying, Fion W O ^a   Yeung, Rebecca M W ^d  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Cancer treatment; Health related quality of life; Oropharyngeal mucositis; Psychometric properties

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MELPHALAN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COLORECTAL CANCER; CRONBACH ALPHA COEFFICIENT; DRUG MEGADOSE; FEMALE; HUMAN; INTERNAL CONSISTENCY; LUNG CANCER; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; OROPHARYNGEAL MUCOSITIS; ORORPHARYNGEAL MUCOSITIS; PHARYNX DISEASE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITATIVE ANALYSIS; QUALITY OF LIFE; TEST RETEST RELIABILITY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOCUS GROUPS; HEALTH STATUS INDICATORS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MUCOSITIS; NEOPLASMS; OROPHARYNX; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL BEHAVIOR;

EID: 34250203600     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22730     Document Type: Article

References (42)

1. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Disease. 2006;12:229-241.
2. Trotte A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253-262.
3. Blijlevens NM, Donnelly JP, De Pauw. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant. 2000;25: 1269-1278.
4. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-2598.
5. Ronien K, Schubert MM, Bruemmer B, et al. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol. 2004;22:1268-1275.
6. Sonis ST, Etling LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer. 2004;100:1995-2025.
7. Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Cancer. 2003;98:1521-1539.
8. Fanning SR, Rybicki L, Kalaycio M, et al. Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol. 2006;135:374-381.
9. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19:2201-2205.
10. Borbasi S, Cameron K, Quested B, et al. More than a sore mouth: patients' experience of oral mucositis. Oncol Nurs Forum. 2002;29:183-205.
11. Cheng KKF. Oropharyngeal mucositis and quality of life of Hong Kong Chinese patients with cancer therapy. Eur J Oncol Nurs. 2007;11:36-42.
12. Cheng KKF. Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs. 2007. In press.
13. Dodd MJ, Dibble S, Miaskowski C, et al. A comparison of the affective state and quality of life of chemotherapy patients who do not and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manag. 2001;21: 498-505.
14. Rose-Ped AM, Bellm LA, Epstein JB, et al. Complications of radiation therapy for head and neck cancers: the patient's perspective. Cancer Nurs. 2002;25:461-467.
15. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004;2:3-8.
16. Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment [Review]. Cochrane Database Syst Rev. 2007;2: CD001972.
17. Multinational Association of Supportive Care in Cancer/ International Society of Oral Oncology. Summary of evidence-based clinical practice guidelines for care of patients with oral and gastrointestinal mucositis [2005 update]. Available from URL: http://www.mascc.org/media/Resource_ centers/ Guidelines_mucositis.doc
18. Stiff PJ, Emmanouilides C, Bensinger WI, et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. J Clin Oncol. 2006;24:5186-5193.
19. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
20. Gotay CC, Blaine D, Haynes SN, et al. Assessment of quality of life in a multicultural cancer patient population. Psychol Assess. 2002;14:439-450.
21. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol. 1994;12:608-616.
22. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. New York: John Wiley & Sons; 2001.
23. Osoba D, Zee B, Pater D, et al. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res. 1994;3:353-364.
24. Sherman AC, Simonton S, Adams DC, et al. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 2000;126:459-467.
25. List MA, D'Antonio LL, Cella DF, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: a study of utility and validity. Cancer. 1996;77:2294-2301.
26. Trotti A, Johnson DJ, Gwede C, et al. Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI). Int J Radiat Oncol Biol Phys. 1998;42:257-261.
27. Haynes SN, Richard DCS, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess. 1995;7:238-247.
28. Vogt DS, King DW, King LA. Focus groups in psychological assessment: enhancing content validity by consulting members of the target population. Psychol Assess. 2004;16: 231-243.
29. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 3rd ed. Oxford: Oxford University Press; 2003.
30. Davis LL. Instrument review: getting the most from a panel of experts. Appl Nurs Res. 1992;5:194-197.
31. Gorusch RL. Factor Analysis. 2nd ed. Philadelphia: WB Saunders; 1983.
32. Henderick AE, White PO. Promax: a quick method for rotation to oblique simple structure. Br J Stat Psychol. 1964;17:65-70.
33. Pett MA, Lackey NR, Sullivan JJ. Making Sense of Factor Analysis: The Use of Factor Analysis in Health Care Research. Thousand Oaks, CA: Sage Publications; 2003.
34. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
35. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
36. Cohen J. Coefficient alpha and the internal structure of a test. Psychometrika. 1986;16:296-334.
37. Denegar CR, Ball DW. Assessing reliability and precision of measurement: an introduction to intraclass correlation and standard error of measurement. J Sport Rehab. 1993;2:35-42.
38. Alexander M, Berger W, Buchholz P, et al. The reliability, validity, and preliminary responsiveness of the eye allergy patient impact questionnaire. Health Qual Life Outcome. 2005;3:67.
39. Landis J, Koch G. The measurement of observed agreement for categorical data. Biometrics. 1977;33:159-174.
40. Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res. 1993;2:367-368.
41. Sireci SG. The construct of content validity. Soc Indic Res. 1998;45:83-117.
42. Samsa G, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcome. 2004;2:1-11.